Literature DB >> 1522238

Disorders of bile acid metabolism in cholesterol gallstone disease.

F Berr1, E Pratschke, S Fischer, G Paumgartner.   

Abstract

The aim of the study was to evaluate the metabolism of individual bile acids in patients with cholesterol gallstone disease. Therefore, we determined pool size and turnover of deoxycholic (DCA), cholic (CA), and chenodeoxycholic acid (CDCA) in 23 female gallstone patients classified according to their gallbladder function and in 15 healthy female controls. Gallstone patients had normal hepatic bile acid synthesis, but, depending on gallbladder function, differed with respect to turnover and size of the bile acid pools: Patients with well-emptying gallbladder (group A, n = 9) had enhanced turnover and reduced pools of CA (-46%; P less than 0.01 vs. controls) and CDCA (-24%; P less than 0.05), but normal input and size of the DCA pool. With reduced gallbladder emptying (less than 50% of volume; group B, n = 6), turnover and pools of CA, CDCA, and DCA were similar as in controls. Patients with loss of gallbladder reservoir (group C, n = 8) had increased input (+100%; P less than 0.01) and pool size of DCA (+45%; P = 0.07) caused by rapid conversion of CA to DCA, while the pools of CA (-71%; P less than 0.001 vs. controls) and CDCA (-36%; P less than 0.05) were reduced by enhanced turnover. Thus, in patients with cholesterol gallstones, the pools of primary bile acids are diminished, unless gallbladder emptying is reduced. Furthermore, in a subgroup of gallstone patients, who had completely lost gallbladder function, the CA pool is largely replaced by DCA owing to rapid transfer of CA to the DCA pool. This probably contributes to supersaturation of bile with cholesterol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522238      PMCID: PMC329940          DOI: 10.1172/JCI115961

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Effect of decreased gallbladder stimulation on enterohepatic cycling and kinetics of bile acids.

Authors:  G W Hepner
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

Review 2.  Measurement of bile and acid kinetics by isotope dilution in man.

Authors:  A F Hofmann; N Hoffman
Journal:  Gastroenterology       Date:  1974-08       Impact factor: 22.682

3.  Bile salt metabolism and the colon.

Authors:  J S Morris; T S Low-Beer; K W Heaton
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

4.  Effects of cholecystectomy on the kinetics of primary and secondary bile acids.

Authors:  F Berr; F Stellaard; E Pratschke; G Paumgartner
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  The effect of cholecystectomy on bile salt metabolism.

Authors:  E W Pomare; K W Heaton
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

6.  Bile lipid secretion in obese and non-obese individuals with and without gallstones.

Authors:  A Reuben; P N Maton; G M Murphy; R H Dowling
Journal:  Clin Sci (Lond)       Date:  1985-07       Impact factor: 6.124

7.  Bile acid pool size and gallbladder storage capacity in gallstone disease.

Authors:  K Nilsell
Journal:  Scand J Gastroenterol       Date:  1990-04       Impact factor: 2.423

8.  Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.

Authors:  K Nilsell; B Angelin; L Liljeqvist; K Einarsson
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

9.  Bile acid secretion and biliary bile acid composition altered by cholecystectomy.

Authors:  J R Malagelada; V L Go; W H Summerskill; W S Gamble
Journal:  Am J Dig Dis       Date:  1973-06

10.  Abnormal gallbladder emptying in a subgroup of patients with gallstones.

Authors:  I S Pomeranz; E A Shaffer
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

View more
  18 in total

1.  Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals.

Authors:  Olga Renner; Simone Harsch; Silke Matysik; Dieter Lütjohann; Gerd Schmitz; Eduard F Stange
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Authors:  G Mazzella; P Fusaroli; A Pezzoli; F Azzaroli; C Mazzeo; L Zambonin; P Simoni; D Festi; E Roda
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Bile acids in serum and bile of patients with cholesterol gallstone.

Authors:  Tian-Quan Han; Sheng-Dao Zhang; Wen-Hao Tang; Zhao-Yan Jiang
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

4.  Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding protein.

Authors:  Elke Prade; Moritz Tobiasch; Ivana Hitkova; Isabell Schäffer; Fan Lian; Xiangbin Xing; Marc Tänzer; Sandra Rauser; Axel Walch; Marcus Feith; Stefan Post; Christoph Röcken; Roland M Schmid; Matthias P A Ebert; Elke Burgermeister
Journal:  Mol Endocrinol       Date:  2012-04-03

Review 5.  Role of farnesoid X receptor in inflammation and resolution.

Authors:  Firdose Begum Shaik; Durbaka V R Prasad; Venkata Ramireddy Narala
Journal:  Inflamm Res       Date:  2014-11-07       Impact factor: 4.575

6.  A population-based cohort study of symptomatic gallstone disease in diabetic patients.

Authors:  Chi-Ming Liu; Chung-Te Hsu; Chung-Yi Li; Chu-Chieh Chen; Meng-Lun Liu; Jorn-Hon Liu
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

7.  Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression.

Authors:  Olga Renner; Simone Harsch; Elke Schaeffeler; Matthias Schwab; Dietmar M Klass; Wolfgang Kratzer; Eduard F Stange
Journal:  Hum Genet       Date:  2009-01-30       Impact factor: 4.132

8.  Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients.

Authors:  Jorge Herrera; Ludwig Amigo; Constanze Husche; Carlos Benítez; Silvana Zanlungo; Dieter Lütjohann; Juan Francisco Miquel; Flavio Nervi
Journal:  Lipids Health Dis       Date:  2009-12-08       Impact factor: 3.876

9.  Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270 000 Men and Women From 3 US Cohorts and Meta-Analysis.

Authors:  Yan Zheng; Min Xu; Yanping Li; Adela Hruby; Eric B Rimm; Frank B Hu; Janine Wirth; Christine M Albert; Kathryn M Rexrode; JoAnn E Manson; Lu Qi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-08-18       Impact factor: 8.311

10.  A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease.

Authors:  Olga Renner; Simone Harsch; Elke Schaeffeler; Stefan Winter; Matthias Schwab; Marcin Krawczyk; Jonas Rosendahl; Henning Wittenburg; Frank Lammert; Eduard F Stange
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.